ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Jason Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Jason Pharmaceuticals, INC. (Medifast, INC. 401(k) Plan · EIN 52-1237423 · PN 003): $41.83M net assets, 588 active participants, and $19.33 per $10,000 (19.33 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorJason Pharmaceuticals, INC.
Filing IdentifierMedifast, INC. 401(k) Plan · EIN 52-1237423 · PN 003
Plan Category & State401(k) Defined Contribution (MD)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$41.83M
Active Participants588
Direct Admin Fee Rate$19.33 per $10,000 (19.33 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI